Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

NCT06180616 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Overweight and Obesity

Interventions

DRUG: Tirzepatide

Sponsor

Royal North Shore Hospital